Alterations of the human gut microbiome in multiple sclerosis

Cited by (1,001)

Items 101–200 of 1,001

1. Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota
   Baokun He, Thomas K. Hoang, Xiangjun Tian, Christopher M. Taylor, Eugene Blanchard, Meng Luo, Meenakshi B. Bhattacharjee, Jasmin Freeborn, Sinyoung Park, Jacob P. Couturier et al. · 2019 · Frontiers in Immunology
2. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy
   Taraprasad Das, Rajagopalaboopathi Jayasudha, Sama Kalyana Chakravarthy, Gumpili Sai Prashanthi, Archana Bhargava, Mudit Tyagi, Padmaja Kumari Rani, Rajeev Reddy Pappuru, Savitri Sharma, Sisinthy Shivaji · 2021 · Scientific Reports
3. Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases
   Opazo, Maria C., Ortega-Rocha, Elizabeth M., Coronado-Arrázola, Irenice, Bonifaz, Laura C., Boudin, Helene, Neunlist, Michel, Bueno, Susan M., Kalergis, Alexis M., Riedel, Claudia A. · 2018 · Frontiers in Microbiology
4. Current and Future Biomarkers in Multiple Sclerosis
   Jennifer Yang, Maysa Hamade, Qi Wu, Qin Wang, Robert C. Axtell, Shailendra Giri, Yang Mao‐Draayer · 2022 · International Journal of Molecular Sciences
5. The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence
   Ilana Katz Sand · 2018 · Current Nutrition Reports
6. Utilization of the microbiome in personalized medicine
   Karina Ratiner, Dragos Marius Ciocan, Suhaib K. Abdeen, Eran Elinav · 2023 · Nature Reviews Microbiology
7. Microbiota-gut brain axis involvement in neuropsychiatric disorders
   Iannone, Luigi Francesco, Preda, Alberto, Blottière, Hervé M., Clarke, Gerard, Albani, Diego, Belcastro, Vincenzo, Carotenuto, Marco, Cattaneo, Annamaria, Citraro, Rita, Ferraris, Cinzia et al. · 2019 · Expert Review of Neurotherapeutics
8. Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
   Jibran Ahmed, Arun Kumar, Kaushal Parikh, Asad Anwar, Bettina M. Knoll, Carmelo A. Puccio, Hoo G. Chun, Michael Paul Fanucchi, Seah H. Lim · 2018 · OncoImmunology
9. Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls
   Yanan Qiao, Mingtao Wu, Yanhuizhi Feng, Zhichong Zhou, Lei Chen, Fengshan Chen · 2018 · Scientific Reports
10. Defining the gut microbiota in individuals with periodontal diseases: an exploratory study
    Talita Gomes Baêta Lourenço, Sarah J. Spencer, Eric J. Alm, Ana Paula Vieira Colombo · 2018 · Journal of Oral Microbiology
11. Intestinal and fecal pH in human health
    Ryodai Yamamura, Kumi Y. Inoue, Kunihiko Nishino, Seiji Yamasaki · 2023 · Frontiers in Microbiomes
12. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
    Freedman, Samantha N., Shahi, Shailesh K., Mangalam, Ashutosh K. · 2018 · Neurotherapeutics
13. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
    Yonghyun Lee, Nobuhiko Kamada, James Jaehyun Moon · 2021 · Advanced Drug Delivery Reviews
14. Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer’s Disease
    Ruth Alonso, Diana Pisa, Ana M. Fernández-Fernández, Luis Carrasco · 2018 · Frontiers in Aging Neuroscience
15. The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
    Sandra Dedrick, Bharathi Sundaresh, Qian Huang, Claudia Brady, Tessa Yoo, Catherine Tracy Cronin, Caitlin Rudnicki, Michael Flood, Babak Momeni, Johnny Ludvigsson et al. · 2020 · Frontiers in Endocrinology
16. Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study
    Leonard, Maureen M., Valitutti, Francesco, Karathia, Hiren, Pujolassos, Meritxell, Kenyon, Victoria, Fanelli, Brian, Troisi, Jacopo, Subramanian, Poorani, Camhi, Stephanie, Colucci, Angelo et al. · 2021 · Proceedings of the National Academy of Sciences
17. The Role of Diet and Interventions on Multiple Sclerosis: A Review
    Panagiotis Stoiloudis, Evangelia Kesidou, Christos Bakirtzis, Styliani-Aggeliki Sintila, Natalia Konstantinidou, Marina Kleopatra Boziki, Nikolaos Grigoriadis · 2022 · Nutrients
18. Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
    Marina Saresella, Laura Mendozzi, Valentina Rossi, Franca Mazzali, Federica Piancone, Francesca LaRosa, Ivana Marventano, Domenico Caputo, Giovanna E. Felis, Mario Clerici · 2017 · Frontiers in Immunology
19. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
    Fengna Chu, Mingchao Shi, Yue Lang, Donghui Shen, Tao Jin, Jie Zhu, Li Cui · 2018 · Mediators of Inflammation
20. The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases
    Antonina Kurowska, Wojciech Ziemichód, Mariola Herbet, Iwona Piątkowska‐Chmiel · 2023 · Nutrients
21. Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls
    Yongqiong Deng, H Wang, Jian Wei Zhou, Y Mou, G Wang, Xia Xiong · 2018 · Acta Dermato Venereologica
22. A Metagenomic Meta-analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome
    Courtney R. Armour, Stephen Nayfach, Katherine S. Pollard, Thomas J. Sharpton · 2019 · mSystems
23. Implications of Gut Microbiota in Neurodegenerative Diseases
    Haoming Zhang, Yijia Chen, Zifan Wang, Gaijie Xie, Mingming Liu, Boyu Yuan, Hongxia Chai, Wei Wang, Ping Cheng · 2022 · Frontiers in Immunology
24. Biomarkers in Multiple Sclerosis
    Anu Paul, Manuel Comabella, Roopali Gandhi · 2018 · Cold Spring Harbor Perspectives in Medicine
25. Investigation of probiotics in multiple sclerosis
    Tankou, Stephanie K, Regev, Keren, Healy, Brian C, Cox, Laura M, Tjon, Emily, Kivisakk, Pia, Vanande, Isabelle P, Cook, Sandra, Gandhi, Roopali, Glanz, Bonnie et al. · 2018 · Multiple Sclerosis Journal
26. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis
    Qin Zeng, Junli Gong, Xiyuan Liu, Chen Chen, Xiaobo Sun, Huijuan Li, Yifan Zhou, ChunPing Cui, Yuge Wang, Yu Yang et al. · 2019 · Neurochemistry International
27. The fecal microbiome of ALS patients
    Dávid Brenner, Andreas Hiergeist, Carolin Isabel Adis, Benjamin Mayer, André Gessner, Albert Christian Ludolph, Jochen Hans Weishaupt · 2017 · Neurobiology of Aging
28. Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
    Rongzeng Liu, Shushu Du, Lili Zhao, Sahil Jain, Kritika Sahay, Albert Anatolyevich Rizvanov, Vera Lezhnyova, Т И Хайбуллин, Ekaterina Vladimirovna Martynova, Svetlana Francevna Khaiboullina et al. · 2022 · Frontiers in Immunology
29. The aryl hydrocarbon receptor and the gut–brain axis
    Barroso, Andreia, Mahler, João Vitor, Fonseca-Castro, Pedro Henrique, Quintana, Francisco J. · 2021 · Cellular & Molecular Immunology
30. Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier
    Jonathan I Spencer, Jack S. Bell, Gabriele C. DeLuca · 2017 · Journal of Neurology Neurosurgery & Psychiatry
31. Probiotics for Parkinson’s Disease
    Parisa Gazerani · 2019 · International Journal of Molecular Sciences
32. The multiple sclerosis gut microbiota: A systematic review
    Ali Mirza, Jessica D. Forbes, Feng Zhu, Charles Noah Bernstein, Gary Van Domselaar, Morag Graham, Emmanuelle L. Waubant, Helen L. Tremlett · 2019 · Multiple Sclerosis and Related Disorders
33. Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress
    Weijie Zhang, Wan Qu, Hua Wang, He Yan · 2021 · Translational Psychiatry
34. Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders
    Yanqing Zhao, Huijun Yang, Peng Wu, Shuguo Yang, Wenkun Xue, Biao Xu, Sirui Zhang, Bin Tang, Daoxiu Xu · 2024 · Virulence
35. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
    Di Gioia, Diana, Bozzi Cionci, Nicole, Baffoni, Loredana, Amoruso, Angela, Pane, Marco, Mogna, Luca, Gaggìa, Francesca, Lucenti, Maria Ausiliatrice, Bersano, Enrica, Cantello, Roberto et al. · 2020 · BMC Medicine
36. Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis
    Kathryn C. Fitzgerald, Diane Vizthum, Bobbie J. Henry-Barron, Amy Schweitzer, Sandra D. Cassard, Eric Heath Kossoff, Adam L. Hartman, Dimitrios Kapogiannis, Patrick Sean Sullivan, David J. Baer et al. · 2018 · Multiple Sclerosis and Related Disorders
37. Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
    Yifan Zhou, Chunping Cui, Xiaoyu Ma, Wenjing Luo, Song Guo Zheng, Wei Qiu · 2020 · Frontiers in Immunology
38. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer’s Disease
    Yijing Chen, Lihua Fang, Shuo Chen, Haokui Zhou, Yingying Fan, Lin Li, Jing Li, Jinying Xu, Yuewen Chen, Yingfei Ma et al. · 2020 · BioMed Research International
39. Alterations of host-gut microbiome interactions in multiple sclerosis
    Claudia Cantoni, Qingqi Lin, Yair Dorsett, Laura Ghezzi, Zhongmao Liu, Yeming Pan, Kun Chen, Yanhui Han, Zhengze Li, Hang Xiao et al. · 2022 · EBioMedicine
40. Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
    Thomas Sécher, Sahar Kassem, Mehdi Benamar, I Bernard, Michèle Boury, Frédérick Barreau, Éric Oswald, Abdelhadi Saoudi · 2017 · Frontiers in Immunology
41. Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases
    Zhuoxin Li, Jie Zhou, Hao Liang, Li Ye, Liuyan Lan, Fang Lü, Qing Wang, Ting Lei, Xiping Yang, Ping Cui et al. · 2022 · Frontiers in Neuroscience
42. Human Gut Microbiota: Toward an Ecology of Disease
    Susannah Selber‐Hnatiw, Belise Rukundo, Masoumeh Ahmadi, Hayfa Akoubi, Hend Al-Bizri, Adelekan F. Aliu, Tanyi U. Ambeaghen, Lilit Avetisyan, Irmak Bahar, Alexandra Baird et al. · 2017 · Frontiers in Microbiology
43. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
    Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2019 · Brain Behavior and Immunity
44. New and Preliminary Evidence on Altered Oral and Gut Microbiota in Individuals with Autism Spectrum Disorder (ASD): Implications for ASD Diagnosis and Subtyping Based on Microbial Biomarkers
    Xuejun Kong, Jun Liu, Murat Çetinbaş, Ruslan I. Sadreyev, Madelyn Koh, Hui Yu Huang, Adetaye Adeseye, Puhan He, Junli Zhu, H. Russell et al. · 2019 · Nutrients
45. Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
    Maria Pia Amato, Tobias J Derfuss, Bernard Hemmer, Roland Liblau, Xavier Montalbán, Per Soelberg Sørensen, David H. Miller, For the 2016 ECTRIMS Focused Workshop Group, Lars S. Alfredsson, Francesca Aloisi et al. · 2017 · Multiple Sclerosis Journal
46. Evidence-based update on rosacea comorbidities and their common physiologic pathways
    Anna D. Holmes, Julia Spoendlin, Anna Lien-Lun Chien, Hilary E. Baldwin, Anne Lynn S. Chang · 2017 · Journal of the American Academy of Dermatology
47. Multi-omics analysis reveals the influence of genetic and environmental risk factors on developing gut microbiota in infants at risk of celiac disease
    Maureen M. Leonard, Hiren Karathia, Meritxell Pujolassos, Jacopo Troisi, Francesco Valitutti, Poorani Subramanian, Stephanie S. Camhi, Victoria Kenyon, Angelo Colucci, Gloria Serena et al. · 2020 · Microbiome
48. The Gut Microbiome and Multiple Sclerosis
    Javier Ochoa‐Repáraz, Trevor O. Kirby, Lloyd H. Kasper · 2018 · Cold Spring Harbor Perspectives in Medicine
49. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review
    Alba Ordoñez-Rodriguez, Pablo Román, Lola Rueda‐Ruzafa, Ana Campos-Ríos, Diana Cardona · 2023 · International Journal of Environmental Research and Public Health
50. Myelin as a regulator of development of the microbiota-gut-brain axis
    Keogh, Ciara E., Kim, Danielle H.J., Pusceddu, Matteo M., Knotts, Trina A., Rabasa, Gonzalo, Sladek, Jessica A., Hsieh, Michael T., Honeycutt, Mackenzie, Brust-Mascher, Ingrid, Barboza, Mariana et al. · 2021 · Brain, Behavior, and Immunity
51. Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance
    Grishanova, Alevtina Y., Perepechaeva, Maria L. · 2022 · International Journal of Molecular Sciences
52. Comparison of the microbial community structure between inflamed and non‐inflamed sites in patients with ulcerative colitis
    Atsushi Hirano, Junji Umeno, Yasuharu Okamoto, Hiroki Shibata, Yoshitoshi Ogura, Tomohiko Moriyama, Takehiro Torisu, Shin Fujioka, Yuta Fuyuno, Yutaka Kawarabayasi et al. · 2018 · Journal of Gastroenterology and Hepatology
53. The gut microbiome and mental health: advances in research and emerging priorities
    Andrew P. Shoubridge, Jocelyn M. Choo, Alyce M. Martin, Damien J. Keating, Ma‐Li Wong, Júlio Licinio, Geraint B. Rogers · 2022 · Molecular Psychiatry
54. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
    Brian T. Bicknell, Ann D. Liebert, Thomas Julius Borody, GK Herkes, Craig Steven McLachlan, Hosen Kiat · 2023 · International Journal of Molecular Sciences
55. Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice
    Sun, Lijuan, Zhang, Haohao, Cao, Ying, Wang, Chenchen, Zhao, Changhai, Wang, Huaning, Cui, Guangbin, Wang, Meixia, Pan, Yan, Shi, Yupeng et al. · 2019 · International Journal of Medical Sciences
56. Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease
    Spichak, Simon, Bastiaanssen, Thomaz F.S., Berding, Kirsten, Vlckova, Klara, Clarke, Gerard, Dinan, Timothy G., Cryan, John F. · 2021 · Neuroscience & Biobehavioral Reviews
57. Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis
    Shailesh K. Shahi, Samantha N. Freedman, Alexandra C. Murra, Kasra Zarei, Ramakrishna R. Sompallae, Katherine Nicole Gibson-Corley, Nitin J. Karandikar, Joseph A. Murray, Ashutosh Kumar Mangalam · 2019 · Frontiers in Immunology
58. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review
    Mohammad Morshedi, Reza Hashemi, Sara Moazzen, Amirhossein Sahebkar, Elaheh-Sadat Hosseinifard · 2019 · Journal of Neuroinflammation
59. The gut microbiota in multiple sclerosis varies with disease activity
    Florence Thirion, Finn Thorup Sellebjerg, Yong Fan, Liwei Lyu, Tue H. Hansen, Nicolas Pons, Florence Levenez, Benoît Quinquis, Evelina Stankevič, Helle Bach Søndergaard et al. · 2023 · Genome Medicine
60. The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
    Günther, Claudia, Rothhammer, Veit, Karow, Marisa, Neurath, Markus, Winner, Beate · 2021 · International Journal of Molecular Sciences
61. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice
    Hui Wang, Gangduo Wang, Nivedita Banerjee, Yuejin Liang, Xiaotang Du, Paul J. Boor, Kristi Louise Hoffman, M. Firoze Khan · 2021 · Frontiers in Immunology
62. Short-chain fatty acids and gut microbiota in multiple sclerosis
    Pernille Melbye, Anna Olsson, Tue H. Hansen, Helle Bach Søndergaard, Annette Bang Oturai · 2018 · Acta Neurologica Scandinavica
63. Short chain fatty acids, a possible treatment option for autoimmune diseases
    Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, Mohammadreza Mirzababaei, Siavash Parvardeh, Ghazaleh Mohammadi, Marjan Nassiri‐Asl · 2023 · Biomedicine & Pharmacotherapy
64. Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
    Dodiya, Hemraj B., Lutz, Holly L., Weigle, Ian Q., Patel, Priyam, Michalkiewicz, Julia, Roman-Santiago, Carlos J., Zhang, Can Martin, Liang, Yingxia, Srinath, Abhinav, Zhang, Xulun et al. · 2022 · Journal of Experimental Medicine
65. Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition
    Françoise Wilhelmi de Toledo, Franziska Grundler, Cesare Riccardo Sirtori, Massimiliano Ruscica · 2020 · Annals of Medicine
66. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
    Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, Linda M. Castell · 2022 · Nutrients
67. Thinking outside the box: non-canonical targets in multiple sclerosis
    Laura Bierhansl, Hans‐Peter Hartung, Orhan Aktaş, Tobias Ruck, Michael Roden, Sven Guenther Meuth · 2022 · Nature Reviews Drug Discovery
68. Microbiota–gut–brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets
    Ce Chen, Guoqing Wang, Daidi Li, Feng Zhang · 2025 · Molecular Biomedicine
69. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract—evidence from next‐generation sequencing studies
    Macke, Lukas, Schulz, Christian, Koletzko, Leandra, Malfertheiner, Peter · 2020 · Alimentary Pharmacology & Therapeutics
70. Gut microbiome-mediated regulation of neuroinflammation
    John W. Bostick, Aubrey M Schonhoff, Sarkis K. Mazmanian · 2022 · Current Opinion in Immunology
71. Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview
    Hanna Ilchmann-Diounou, Sandrine Ménard · 2020 · Frontiers in Immunology
72. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity
    Theresa L. Montgomery, Axel Künstner, Josephine J. Kennedy, Qian Fang, Lori Asarian, Rachel Culp‐Hill, Angelo D’Alessandro, Cory Teuscher, Hauke S. Busch, Dimitry N. Krementsov · 2020 · Proceedings of the National Academy of Sciences
73. Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium
    Keith A. Sharkey, Paul L. Beck, Derek Mark McKay · 2018 · Nature Reviews Gastroenterology & Hepatology
74. Targeting the gut to treat multiple sclerosis
    Laura Ghezzi, Claudia Cantoni, Gabriela Veronica Pinget, Yanjiao Zhou, Laura Piccio · 2021 · Journal of Clinical Investigation
75. Alteration of Gut Microbiota in Patients With Epilepsy and the Potential Index as a Biomarker
    Xue Gong, Xu Liu, Chu Chen, Jingfang Lin, Aiqing Li, Kundian Guo, Dongmei An, Dong Zhou, Zhen Hong · 2020 · Frontiers in Microbiology
76. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283
    EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Jacqueline J. M. Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska et al. · 2021 · EFSA Journal
77. Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders
    Andréa Rodrigues Vasconcelos, Nilton Barreto dos Santos, Cristóforo Scavone, Carolina Demarchi Munhoz · 2019 · Frontiers in Pharmacology
78. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
    Tatjana Reynders, Lindsay Devolder, Mireia Valles‐Colomer, Ann Van Remoortel, Marie Joossens, Jacques De Keyser, Guy Nagels, Marie Beatrice D'hooghe, Jeroen Raes · 2020 · Annals of Clinical and Translational Neurology
79. GDP- l -fucose synthase is a CD4 + T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis
    Raquel Planas, Radleigh G. Santos, Paula Tomas Ojer, Carolina Cruciani, Andreas Lutterotti, Wolfgang Faigle, Nicole Schaeren‐Wiemers, Carmen Espejo, Herena Eixarch, Clemencia Pinilla et al. · 2018 · Science Translational Medicine
80. Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair
    Ilias Kalafatakis, Domna Karagogeos · 2021 · Biomolecules
81. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression : Towards Characterization of the “MS Microbiome.”
    Pröbstel, Anne-Katrin, Baranzini, Sergio E. · 2018 · Neurotherapeutics
82. The gut microbiome in epilepsy
    Birol Şafak, Bengü Altunan, Birol Topçu, Aynur Eren Topkaya · 2019 · Microbial Pathogenesis
83. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders
    Sankar Simla Praveenraj, Sharma Sonali, Nikhilesh Anand, Tousif Ahmed Hediyal, Chandrasekaran Vichitra, Manjunath Kalyan, Perumalswamy Velumani Kanna, Kumar A. Chandana, Shasthara Paneyala, Arehally Marappa Mahalakshmi et al. · 2022 · Molecular Neurobiology
84. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation
    Pavan Bhargava, Kathryn C. Fitzgerald, Peter A. Calabresi, Ellen M. Mowry · 2017 · JCI Insight
85. Invited Review: From nose to gut – the role of the microbiome in neurological disease
    Jack S. Bell, Jonathan I Spencer, Richard L. Yates, Sydney A. Yee, Benjamin M. Jacobs, Gabriele C. DeLuca · 2018 · Neuropathology and Applied Neurobiology
86. The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
    Winek, Katarzyna, Dirnagl, Ulrich, Meisel, Andreas · 2016 · Neurotherapeutics
87. Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation
    Sebastian Zundler, Claudia Günther, Andreas Emanuel Kremer, Mario M. Zaiss, Veit Rothhammer, Markus Friedrich Neurath · 2022 · Nature Reviews Gastroenterology & Hepatology
88. The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
    Pei Yee Tiew, Micheál Mac Aogáin, Nur A’tikah Binte Mohamed Ali, Kai Xian Thng, Karlyn Goh, Kenny J. X. Lau, Sanjay Haresh Chotirmall · 2020 · Mycopathologia
89. Glioma and temozolomide induced alterations in gut microbiome
    Anthony Patrizz, Antonio Dono, Soheil Zorofchian, Gabriella Hines, Takeshi Takayasu, Nuruddin Husein, Yoshihiro Otani, Octavio Arevalo, Huimahn Alex Choi, Jude P. J. Savarraj et al. · 2020 · Scientific Reports
90. Disease-modifying therapies alter gut microbial composition in MS
    Ilana Katz Sand, Yunjiao Zhu, Achilles Ntranos, José C. Clemente, Egle Cekanaviciute, Rachel Brandstadter, Elizabeth Crabtree‐Hartman, Sneha Singh, Yadira Bencosme, Justine W. Debelius et al. · 2018 · Neurology Neuroimmunology & Neuroinflammation
91. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
    Craig Haifer, Colleen R. Kelly, Sudarshan Paramsothy, David N. Andresen, Lito E. Papanicolas, Genevieve L. McKew, Thomas Julius Borody, Michael A. Kamm, Samuel Paul Costello, Jane Mary Andrews et al. · 2020 · Gut
92. Gut Microbiota Interaction with the Central Nervous System throughout Life
    Jorge Ojeda, Ariel Ávila, Pia Maria Vidal · 2021 · Journal of Clinical Medicine
93. The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
    Trevor O. Kirby, Javier Ochoa‐Repáraz · 2018 · Medical Sciences
94. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
    Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani · 2023 · Nutrients
95. Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course
    Rachel E. Ventura, Tadasu Iizumi, Thomas Battaglia, Menghan Liu, G. I. Perez-Perez, Joseph Herbert, Martin J. Blaser · 2019 · Scientific Reports
96. Akkermansia muciniphila, which is enriched in the gut microbiota by metformin, improves cognitive function in aged mice by reducing the proinflammatory cytokine interleukin-6
    Xiaoqi Zhu, Junyan Shen, Shengyu Feng, Ce Huang, Hao Wang, Fengjiao Huo, Hailiang Liu · 2023 · Microbiome
97. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease
    Dimitri N. Koutzoumis, Macarena Vergara, José A. Pino, Julia Buddendorff, Habibeh Khoshbouei, Ronald J. Mandel, Gonzalo E. Torres · 2019 · Experimental Neurology
98. Regulation of Astrocyte Functions in Multiple Sclerosis
    Michael A. Wheeler, Francisco Javier Quintana · 2018 · Cold Spring Harbor Perspectives in Medicine
99. Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers
    Hartmut Wekerle · 2017 · Trends in Immunology
100. Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma
     Achilles Ntranos, Hye-Jin Park, Maureen Wentling, Vladimir Tolstikov, Mario Amatruda, Benjamin Inbar, Seunghee Kim‐Schulze, Carol Frazier, Judy Button, Michael A. Kiebish et al. · 2021 · Brain